Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2020-11-02 | Dr. Gilad Aharon was appointed as a director of the Company in May 2020. The current members of the Compensation and Stock Option Committee are Roger G. Stoll (Chair), Elizabeth Czerepak and Dr. Gilad Aharon. |
Data sourced from SEC filings. Last updated: 2025-12-07